
Marksans Pharma Limited has informed the Exchange regarding a press release dated January 20, 2023, titled "Marksans Pharma raises Rs. 372.40 crores in equity via conversion of warrants issued to OrbiMed and the Promoter".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated January 20, 2023, titled "Marksans Pharma raises Rs. 372.40 crores in equity via conversion of warrants issued to OrbiMed and the Promoter".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma